Magnetic resonance methods and applications in pharmaceutical research.

This review presents an overview of some recent magnetic resonance (MR) techniques for pharmaceutical research. MR is noninvasive, and does not expose subjects to ionizing radiation. Some methods that have been used in pharmaceutical research MR include magnetic resonance spectroscopy (MRS) and magnetic resonance imaging (MRI) methods, among them, diffusion-weighted MRI, perfusion-weighted MRI, functional MRI, molecular imaging and contrast-enhance MRI. Some applications of MR in pharmaceutical research include MR in metabonomics, in vivo MRS, studies in cerebral ischemia and infarction, degenerative joint diseases, oncology, cardiovascular disorders, respiratory diseases and skin diseases. Some of these techniques, such as cardiac and joint imaging, or brain fMRI are standard, and are providing relevant data routinely. Skin MR and hyperpolarized gas lung MRI are still experimental. In conclusion, considering the importance of finding and characterizing biomarkers for improved drug evaluation, it can be expected that the use of MR techniques in pharmaceutical research is going to increase in the near future.

[1]  J. Ruíz-Cabello,et al.  Measurement of pharmacodynamic effects of dexamethasone on epidermis by phosphorus nuclear magnetic resonance spectroscopy in vitro. , 1994, Journal of pharmaceutical sciences.

[2]  D. I. Hoult,et al.  Observation of tissue metabolites using 31P nuclear magnetic resonance , 1974, Nature.

[3]  N Weiler,et al.  Quantification of regional intrapulmonary oxygen partial pressure evolution during apnea by (3)He MRI. , 1999, Journal of magnetic resonance.

[4]  M. Rudin,et al.  In vivo assessment of macromolecular content in articular cartilage of the goat knee , 2003, Magnetic resonance in medicine.

[5]  I. Smith,et al.  Magnetic resonance spectroscopy in medicine: clinical impact , 2002 .

[6]  J. Fozard,et al.  Pulmonary inflammation monitored noninvasively by MRI in freely breathing rats. , 2002, Biochemical and biophysical research communications.

[7]  B. Cho,et al.  Delayed diagnosis of cerebellar hemangioblastoma after intracerebellar hemorrhage. , 2007, Surgical neurology.

[8]  M Thelen,et al.  Imaging of the lungs using 3he MRI: Preliminary clinical experience in 18 patients with and without lung disease , 1997, Journal of magnetic resonance imaging : JMRI.

[9]  B. Banwell,et al.  MRI features of pediatric multiple sclerosis , 2007, Neurology.

[10]  E. Purcell,et al.  Resonance Absorption by Nuclear Magnetic Moments in a Solid , 1946 .

[11]  R. Wilson,et al.  Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. , 1998, Medical physics.

[12]  D M Shames,et al.  MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. , 2001, Radiology.

[13]  Magnetic Resonance Imaging of Animal Brain In Vivo , 2006 .

[14]  Yu-Chung N. Cheng,et al.  Magnetic Resonance Imaging: Physical Principles and Sequence Design , 1999 .

[15]  J. L. López-Lacomba,et al.  Effects of ethanol and dexamethasone on epidermis examined by in vitro 31P magnetic resonance spectroscopy. , 1998, Journal of pharmaceutical sciences.

[16]  S. Caruthers,et al.  Molecular imaging and therapy of atherosclerosis with targeted nanoparticles , 2007, Journal of magnetic resonance imaging : JMRI.

[17]  V. Callot,et al.  Helium-3 MRI diffusion coefficient: correlation to morphometry in a model of mild emphysema , 2003, European Respiratory Journal.

[18]  M. Rausch,et al.  Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage , 2001, Magnetic resonance in medicine.

[19]  R. Jacobs,et al.  Three-dimensional digital mouse atlas using high-resolution MRI. , 2001, Developmental biology.

[20]  V. Wedeen,et al.  Diffusion Tensor Magnetic Resonance Imaging Mapping the Fiber Architecture Remodeling in Human Myocardium After Infarction: Correlation With Viability and Wall Motion , 2006, Circulation.

[21]  Determination of rat heart morphology and function in vivo in two models of cardiac hypertrophy by means of magnetic resonance imaging , 2005, Basic Research in Cardiology.

[22]  C. Rinker-Schaeffer,et al.  Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI , 2001, Magnetic resonance in medicine.

[23]  M. Santacana,et al.  Effects of oxygen and glucose deprivation on the expression and distribution of neuronal and inducible nitric oxide synthases and on protein nitration in rat cerebral cortex , 2002, The Journal of comparative neurology.

[24]  D Artemov,et al.  Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging. , 1998, Cancer research.

[25]  John C. Lindon,et al.  NMR Spectroscopy: Principles and Instrumentation , 2005 .

[26]  C. Mountford,et al.  Assessment of human colorectal biopsies by 1H MRS: Correlation with histopathology , 1993, Magnetic resonance in medicine.

[27]  N. Beckmann,et al.  Effects of Sandimmune neoral on collagen-induced arthritis in DA rats: characterization by high resolution three-dimensional magnetic resonance imaging and by histology. , 1998, Journal of magnetic resonance.

[28]  R. S. Hinks,et al.  Time course EPI of human brain function during task activation , 1992, Magnetic resonance in medicine.

[29]  Robert E Lenkinski,et al.  PARACEST agents: modulating MRI contrast via water proton exchange. , 2003, Accounts of chemical research.

[30]  C. Sunderland,et al.  Targeted nanoparticles for detecting and treating cancer , 2006 .

[31]  G. V. von Schulthess,et al.  Assessment of Myocardial Perfusion in Coronary Artery Disease by Magnetic Resonance: A Comparison With Positron Emission Tomography and Coronary Angiography , 2001, Circulation.

[32]  J. Fozard,et al.  Resolution of the oedema associated with allergic pulmonary inflammation in rats assessed noninvasively by magnetic resonance imaging , 2003, British journal of pharmacology.

[33]  A. Gunduz,et al.  Intrathecal Gadolinium‐Enhanced MR‐Cisternography in Spontaneous Intracranial Hypotension Associated With Behcet's Syndrome , 2007, Headache.

[34]  C. Higgins,et al.  Pulmonary edema: an MR study of permeability and hydrostatic types in animals. , 1986, Radiology.

[35]  Irene Tracey,et al.  Pharmacological fMRI: A New Tool for Drug Development in Humans , 2001 .

[36]  D. Šuput,et al.  Water proton NMR relaxation mechanisms in lung tissue , 1988, Magnetic resonance in medicine.

[37]  Robert G. Weiss,et al.  Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium , 2006, Circulation.

[38]  H. Wen,et al.  High-resolution strain analysis of the human heart with fast-DENSE. , 1999, Journal of magnetic resonance.

[39]  J. Fozard,et al.  MRI of lung parenchyma in rats and mice using a gradient‐echo sequence , 2001, NMR in biomedicine.

[40]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[41]  I. Wilson,et al.  Directly coupled HPLC-NMR and its application to drug metabolism. , 1997, Drug metabolism reviews.

[42]  Mehmet Bilgen,et al.  Manganese-enhanced MRI of rat spinal cord injury. , 2005, Magnetic resonance imaging.

[43]  Amber Denomme,et al.  Pulmonary edema. , 1988, Journal of thoracic imaging.

[44]  Martin J. Lohse,et al.  Dobutamine-Stress Magnetic Resonance Microimaging in Mice: Acute Changes of Cardiac Geometry and Function in Normal and Failing Murine Hearts , 2001, Circulation research.

[45]  W. V. van Gilst,et al.  The effects of short- and long-term treatment with an ACE-inhibitor in rats with myocardial infarction. , 1991, Basic research in cardiology.

[46]  J. Fozard,et al.  Techniques: magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs. , 2003, Trends in pharmacological sciences.

[47]  T. Kieber‐Emmons,et al.  Applying in vitro NMR spectroscopy and 1H NMR metabonomics to breast cancer characterization and detection , 2005 .

[48]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[49]  M D King,et al.  Identification of Collaterally Perfused Areas following Focal Cerebral Ischemia in the Rat by Comparison of Gradient Echo and Diffusion-Weighted MRI , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  Gregory S Karczmar,et al.  MRI of the tumor microenvironment , 2002, Journal of magnetic resonance imaging : JMRI.

[51]  G. Guillot,et al.  Magnetic susceptibility matching at the air–tissue interface in rat lung by using a superparamagnetic intravascular contrast agent: Influence on transverse relaxation time of hyperpolarized helium‐3 , 2005, Magnetic resonance in medicine.

[52]  L W Hedlund,et al.  Time‐course imaging of rat embryos in utero with magnetic resonance microscopy , 1998, Magnetic resonance in medicine.

[53]  J R Griffiths,et al.  Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours , 2001, NMR in biomedicine.

[54]  D Artemov,et al.  Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors. , 2001, Cancer research.

[55]  G. Bydder,et al.  NMR imaging of the brain using spin-echo sequences. , 1982, Clinical Radiology.

[56]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[57]  In vitro measurements of water content and T2 relaxation times in lung using a clinical MRI scanner , 1999, Journal of magnetic resonance imaging : JMRI.

[58]  Leo L. Cheng,et al.  Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. , 2005, Cancer research.

[59]  John C. Lindon,et al.  Metabonomics in toxicity assessment , 2005 .

[60]  Ying Wang,et al.  Regional myocardial blood volume and flow: First‐pass MR imaging with polylysine‐Gd‐DTPA , 1995, Journal of magnetic resonance imaging : JMRI.

[61]  Steven Warach,et al.  Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. , 2003, Journal of vascular and interventional radiology : JVIR.

[62]  N. Osman,et al.  Comparison between tagged MRI and standard cine MRI for evaluation of left ventricular ejection fraction , 2004, European Radiology.

[63]  Julian L Griffin,et al.  Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. , 2003, Current opinion in chemical biology.

[64]  B. Querleux Magnetic resonance imaging and spectroscopy of skin and subcutis , 2004, Journal of cosmetic dermatology.

[65]  B R Rosen,et al.  Functional magnetic resonance imaging of reorganization in rat brain after stroke , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Mathias Hoehn,et al.  Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Hans-Ulrich Kauczor,et al.  Morphological and functional imaging in COPD with CT and MRI: present and future , 2008, European Radiology.

[68]  A Haase,et al.  Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[69]  Marcelino Bernardo,et al.  Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imaging. , 2005, Bioconjugate chemistry.

[70]  D. Burstein,et al.  Gd‐DTPA2− as a measure of cartilage degradation , 1996, Magnetic resonance in medicine.

[71]  M. Rudin,et al.  Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. , 1986, Stroke.

[72]  Markus Rudin,et al.  Magnetic resonance imaging in biomedical research: imaging of drugs and drug effects. , 2004, Methods in enzymology.

[73]  W. Hundley,et al.  Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. , 1999, Circulation.

[74]  P Altmeyer,et al.  Improved resolution of magnetic resonance microscopy in examination of skin tumors. , 1996, The Journal of investigative dermatology.

[75]  L W Hedlund,et al.  Histology by magnetic resonance microscopy. , 1993, Magnetic resonance quarterly.

[76]  F. Korosec,et al.  Functional lung imaging using hyperpolarized gas MRI , 2007, Journal of magnetic resonance imaging : JMRI.

[77]  P R Allegrini,et al.  Application of magnetic resonance imaging to the measurement of neurodegeneration in rat brain: MRI data correlate strongly with histology and enzymatic analysis. , 1992, Magnetic resonance imaging.

[78]  L W Hedlund,et al.  In vivo He-3 MR images of guinea pig lungs. , 1996, Radiology.

[79]  S. Harms,et al.  Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. , 2005, American journal of surgery.

[80]  Dennis W J Klomp,et al.  Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver , 2003, Magnetic resonance in medicine.

[81]  Dmitri Artemov,et al.  MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles , 2003, Magnetic resonance in medicine.

[82]  D. Graham,et al.  Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  O Jolivet,et al.  In vivo hydration profile in skin layers by high-resolution magnetic resonance imaging. , 1994, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[84]  E. Fleck,et al.  High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. , 2004, Radiology.

[85]  Richard G. Wise,et al.  Combining fMRI with a Pharmacokinetic Model to Determine Which Brain Areas Activated by Painful Stimulation Are Specifically Modulated by Remifentanil , 2002, NeuroImage.

[86]  Rika Takikawa,et al.  [In-vivo visualization of gene expression using magnetic resonance imaging]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[87]  R. Gillies,et al.  In vivo magnetic resonance spectroscopy in cancer. , 2005, Annual review of biomedical engineering.

[88]  J. VanMeter,et al.  Contrast-Enhanced In Vivo Imaging of Breast and Prostate Cancer Cells by MRI , 2006, Cell cycle.

[89]  S. Ogawa,et al.  Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields , 1990, Magnetic resonance in medicine.

[90]  R. Hof,et al.  Effect of Spirapril on Left Ventricular Hypertrophy Due to Volume Overload in Rats , 1992, Journal of cardiovascular pharmacology.

[91]  R. Felix,et al.  Young Investigator Award Presentation at the 13th Annual Meeting of the ESMRMB, September 1996, Prague Quantification of pulmonary water compartments by magnetic resonance , 1997, Magnetic Resonance Materials in Physics, Biology and Medicine.

[92]  M. Hofmann,et al.  750 MHz HPLC-NMR spectroscopic identification of rat microsomal metabolites of phenoxypyridines. , 1997, Journal of pharmaceutical and biomedical analysis.

[93]  R. Weissleder,et al.  Detection of lymph node metastases by contrast‐enhanced MRI in an experimental model , 2002, Magnetic resonance in medicine.

[94]  M Hoehn-Berlage,et al.  Relationship between diffusion-weighted MR images, cerebral blood flow, and energy state in experimental brain infarction. , 1995, Magnetic resonance imaging.

[95]  Scott E. Fraser,et al.  Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study , 2004, NeuroImage.

[96]  H. Wen,et al.  DENSE: displacement encoding with stimulated echoes in cardiac functional MRI. , 1999, Journal of magnetic resonance.

[97]  S. Ogawa Brain magnetic resonance imaging with contrast-dependent oxygenation , 1990 .

[98]  M. Moseley,et al.  Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion. , 1992, Radiology.

[99]  E J van Beek,et al.  Pulmonary ventilation imaged by magnetic resonance: at the doorstep of clinical application. , 2001, The European respiratory journal.

[100]  Kevin M. Johnson,et al.  Dysprosium‐bearing red cells as potential transverse relaxation agents for MRI , 2001, Magnetic resonance in medicine.

[101]  J. Frank,et al.  Cellular magnetic resonance imaging: current status and future prospects , 2006, Expert review of medical devices.

[102]  J. Hu,et al.  Localized in vivo isotropic‐anisotropic correlation 1H NMR spectroscopy using ultraslow magic angle spinning , 2006, Magnetic resonance in medicine.

[103]  M. Brechbiel,et al.  Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores , 2001, Magnetic resonance in medicine.

[104]  R Felix,et al.  Role of High-Resolution Magnetic Resonance Imaging for Differentiating Melanin-Containing Skin Tumors , 1995, Investigative radiology.

[105]  J. Fozard,et al.  Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[106]  R. Günther,et al.  Feasibility of Pulmonary Ventilation Visualization With Aerosolized Magnetic Resonance Contrast Media , 2005, Investigative radiology.

[107]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[108]  M V Knopp,et al.  Dynamic contrast-enhanced magnetic resonance imaging in oncology. , 2001, Topics in magnetic resonance imaging : TMRI.

[109]  K. Suga,et al.  Assessment of regional lung ventilation in dog lungs with Gd-DTPA aerosol ventilation MR imaging , 2002 .

[110]  Matthias Nahrendorf,et al.  In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[111]  Michael Jerosch-Herold,et al.  Assessment of Ischemic Heart Disease Using Magnetic Resonance First-Pass Perfusion Imaging , 2003, Herz.

[112]  J. Timbrell Overview of Biomarkers , 2005 .

[113]  Piotr Walczak,et al.  Artificial reporter gene providing MRI contrast based on proton exchange , 2007, Nature Biotechnology.

[114]  Bernard Querleux,et al.  Advances in MR imaging of the skin , 2006, NMR in biomedicine.

[115]  H. Kauczor,et al.  MRI of the pulmonary parenchyma , 1999, European Radiology.

[116]  H. Kauczor,et al.  Analysis of intrapulmonary O(2) concentration by MR imaging of inhaled hyperpolarized helium-3. , 1999, Journal of applied physiology.

[117]  G. J. Strijkers,et al.  Magnetic resonance imaging of regional cardiac function in the mouse , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[118]  R. Weissleder Molecular Imaging in Cancer , 2006, Science.

[119]  R. E. de Souza,et al.  Manganese‐enhanced magnetic resonance imaging (MEMRI) of rat brain after systemic administration of MnCl2: Changes in T1 relaxation times during postnatal development , 2007, Journal of magnetic resonance imaging : JMRI.

[120]  F. Franconi,et al.  Evaluating SPIO‐labelled cell MR efficiency by three‐dimensional quantitative T  2* MRI , 2007, NMR in biomedicine.

[121]  M. Rausch,et al.  Recovery of function in cytoprotected cerebral cortex in rat stroke model assessed by functional MRI , 2002, Magnetic resonance in medicine.

[122]  J. E. Tanner,et al.  Spin diffusion measurements : spin echoes in the presence of a time-dependent field gradient , 1965 .

[123]  M. Ruhnke,et al.  CNS Aspergillosis , 2007, CNS drugs.

[124]  Enzo Terreno,et al.  From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons. , 2007, Angewandte Chemie.

[125]  C G Peterfy,et al.  Magnetic resonance imaging in rheumatoid arthritis: current status and future directions. , 2001, The Journal of rheumatology.

[126]  H. Hricak,et al.  Molecular MR imaging in oncology. , 2005, Magnetic resonance imaging clinics of North America.

[127]  S. H. Koenig From the relaxivity of Gd(DTPA)2− to everything else , 1991, Magnetic resonance in medicine.

[128]  W. W. Hansen,et al.  The Nuclear Induction Experiment , 1946 .

[129]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[130]  Lawrence J. Berliner,et al.  Biological Magnetic Resonance , 2002, Biological Magnetic Resonance.

[131]  J. Strzelczyk The Essential Physics of Medical Imaging , 2003 .

[132]  S. Laurent,et al.  Dy-complexes as high field T2 contrast agents: influence of water exchange rates. , 2002, Academic radiology.

[133]  R. Weissleder,et al.  Molecular Imaging of Factor XIIIa Activity in Thrombosis Using a Novel, Near-Infrared Fluorescent Contrast Agent That Covalently Links to Thrombi , 2004, Circulation.

[134]  Guy Marchal,et al.  Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agent , 2006, European Radiology.

[135]  B. Bonnemain Pharmacokinetic and hemodynamic safety of two superparamagnetic agents, Endorem and Sinerem, in cirrhotic rats. , 1998, Academic radiology.

[136]  J. Griffiths,et al.  In vivo detection of ifosfamide by 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas. , 1997, British Journal of Cancer.

[137]  G. Parker,et al.  DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents , 2007, British Journal of Cancer.

[138]  Udo Sechtem,et al.  Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. , 2006, Journal of the American College of Cardiology.

[139]  Markus Rudin,et al.  Impaired functionality of reperfused brain tissue following short transient focal ischemia in rats. , 2002, Magnetic resonance imaging.

[140]  S. Ogawa,et al.  The sensitivity of magnetic resonance image signals of a rat brain to changes in the cerebral venous blood oxygenation , 1993, Magnetic resonance in medicine.

[141]  H. Wen,et al.  Mixed echo train acquisition displacement encoding with stimulated echoes: An optimized DENSE method for in vivo functional imaging of the human heart , 2001, Magnetic resonance in medicine.

[142]  C. Higgins,et al.  Assessment of nicorandil therapy in ischemic myocardial injury by using contrast-enhanced and functional MR imaging. , 2001, Radiology.

[143]  D. Tank,et al.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[144]  C Zimmer,et al.  Magnetic labeling of activated microglia in experimental gliomas. , 2001, Neoplasia.

[145]  Klaas Nicolay,et al.  MRI contrast agents: current status and future perspectives. , 2007, Anti-cancer agents in medicinal chemistry.

[146]  M. Rudin,et al.  In-vivo cardiac studies in animals using magnetic resonance techniques: experimental aspects and MR readouts , 2000, Magma: Magnetic Resonance Materials in Physics, Biology, and Medicine.

[147]  E. R. Andrew,et al.  The narrowing of NMR spectra of solids by high-speed specimen rotation and the resolution of chemical shift and spin multiplet structures for solids . Pulsed NMR in Solids , 1971 .

[148]  P. Barker,et al.  In vivo proton MR spectroscopy of the human brain , 2006 .

[149]  Meiyappan Solaiyappan,et al.  Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[150]  J. Kucharczyk,et al.  Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.

[151]  M. Cutolo Macrophages as Effectors of the Immunoendocrinologic Interactions in Autoimmune Rheumatic Diseases a , 1999, Annals of the New York Academy of Sciences.

[152]  Donald G Robertson,et al.  Metabonomics in toxicology: a review. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[153]  B. Rosen,et al.  Functional magnetic resonance imaging. , 1995, Academic radiology.

[154]  Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases , 2003, Journal of magnetic resonance imaging : JMRI.

[155]  Ralph Weissleder,et al.  Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.

[156]  E. Fleck,et al.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.

[157]  Arend Heerschap,et al.  19F-magnetic resonance spectroscopy in patients with liver metastases of colorectal cancer treated with 5-fluorouracil , 2004, Anti-cancer drugs.

[158]  R. Turner,et al.  Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[159]  D. Gadian,et al.  Phosphorus nuclear magnetic resonance studies on normoxic and ischemic cardiac tissue. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[160]  Jinyuan Zhou,et al.  Chemical exchange saturation transfer imaging and spectroscopy , 2006 .

[161]  Gabriel P Krestin,et al.  Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction. , 2006, Journal of the American College of Cardiology.

[162]  David Borsook,et al.  A role for fMRI in optimizing CNS drug development , 2006, Nature Reviews Drug Discovery.

[163]  H. Oswald,et al.  Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. , 2000, Circulation.

[164]  Terry Hyslop,et al.  Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. , 2007, Trends in biotechnology.

[165]  J R Griffiths,et al.  Proton NMR Observation of the Antineoplastic Agent Iproplatin In Vivo by Selective Multiple Quantum Coherence Transfer (Sel‐MQC) , 1995, Magnetic resonance in medicine.

[166]  A Haase,et al.  Magnetic resonance imaging of coronary arteries and heart valves in a living mouse: techniques and preliminary results. , 2000, Journal of magnetic resonance.

[167]  J. Hennig,et al.  PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. , 2002, Cancer research.

[168]  Dennis W J Klomp,et al.  In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength. , 2003, Cancer research.

[169]  Sean B Fain,et al.  Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. , 2006, Radiology.

[170]  R. Braun,et al.  Manganese-enhanced MRI of human choroidal melanoma xenografts. , 2007, Investigative ophthalmology & visual science.

[171]  Károly Héberger,et al.  Metabolomics applied to exhaled breath condensate in childhood asthma. , 2007, American journal of respiratory and critical care medicine.

[172]  R. Reznek,et al.  Imaging of neuroendocrine tumours (CT/MR/US). , 2007, Best practice & research. Clinical endocrinology & metabolism.

[173]  L W Hedlund,et al.  Detection of emphysema in rat lungs by using magnetic resonance measurements of 3He diffusion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[174]  A. Sherry,et al.  Number of inner‐sphere water molecules in Gd3+ and Eu3+ complexes of DTPA‐amide and ‐ester conjugates , 1988, Magnetic resonance in medicine.

[175]  Stuart S. Berr,et al.  Angiotensin II Type 2 Receptor Overexpression Preserves Left Ventricular Function After Myocardial Infarction , 2002, Circulation.

[176]  C. Corot,et al.  Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation. , 1996, Academic radiology.

[177]  R. Balaban,et al.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.

[178]  E. Ritenour,et al.  Medical Imaging Physics , 1992 .

[179]  Stefan Neubauer,et al.  Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse , 1998, Magnetic resonance in medicine.

[180]  S. H. Koenig,et al.  Magnetic field dependence of solvent proton relaxation rates induced by Gd3+ and Mn2+ complexes of various polyaza macrocyclic ligands: Implications for NMR imaging , 1986, Magnetic resonance in medicine.

[181]  P. Barnes,et al.  Biomarkers of some pulmonary diseases in exhaled breath , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[182]  Charles R. Wilson,et al.  The Essential Physics of Medical Imaging, 2nd Edition , 2003 .

[183]  Luigi Biancone,et al.  Magnetic resonance imaging of gadolinium‐labeled pancreatic islets for experimental transplantation , 2007, NMR in biomedicine.

[184]  W Vennart,et al.  Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[185]  Ray F. Lee,et al.  Diffusional kurtosis imaging in the lung using hyperpolarized 3He , 2006, Magnetic resonance in medicine.

[186]  Jiangsheng Yu,et al.  Advances in magnetic resonance imaging of lung physiology. , 2007, Journal of applied physiology.

[187]  D. Ankerst,et al.  Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis , 2006, Psychiatry Research: Neuroimaging.

[188]  A. Heerschap,et al.  Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy. , 2005, Critical reviews in oncology/hematology.

[189]  Stuart S Berr,et al.  Cardiac overexpression of A1-adenosine receptor protects intact mice against myocardial infarction. , 2002, American journal of physiology. Heart and circulatory physiology.

[190]  G. Miller,et al.  Time dependence of 3He diffusion in the human lung: Measurement in the long‐time regime using stimulated echoes , 2006, Magnetic resonance in medicine.

[191]  N. Beckmann,et al.  High resolution magnetic resonance angiography non‐invasively reveals mouse strain differences in the cerebrovascular anatomy in vivo , 2000, Magnetic resonance in medicine.

[192]  Paul A Bottomley,et al.  ATP flux through creatine kinase in the normal, stressed, and failing human heart. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[193]  Xuxia Wang,et al.  Mn(II)-monosubstituted polyoxometalates as candidates for contrast agents in magnetic resonance imaging. , 2007, Journal of inorganic biochemistry.

[194]  J. Griffiths,et al.  In vivo 19F NMR spectroscopy of the antimetabolite 5-fluorouracil and its analogues. An assessment of drug metabolism. , 1990, Biochemical pharmacology.

[195]  M. Leach,et al.  Initial measurements of ifosfamide and cyclophosphamide in patients using 31P MRS: Pulse‐and‐acquire, decoupling, and polarization transfer , 2000, Magnetic resonance in medicine.

[196]  Evaluation of brain edema using magnetic resonance proton relaxation times. , 1990, Advances in neurology.

[197]  J R Griffiths,et al.  Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy. , 2000, Advanced drug delivery reviews.

[198]  M. Solaiyappan,et al.  In vivo three‐dimensional reconstruction of rat brain axonal projections by diffusion tensor imaging , 1999, Magnetic resonance in medicine.

[199]  Craig H Meyer,et al.  Technology Insight: in vivo cell tracking by use of MRI , 2006, Nature Clinical Practice Cardiovascular Medicine.

[200]  Donald S. Williams,et al.  Perfusion imaging , 1992, Magnetic resonance in medicine.

[201]  Patrick Winter,et al.  Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[202]  P. Hekali,et al.  Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. , 1997, Circulation.

[203]  O Jolivet,et al.  In vivo proton relaxation times analysis of the skin layers by magnetic resonance imaging. , 1991, The Journal of investigative dermatology.

[204]  S. Wrighton,et al.  Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[205]  Frederick H Epstein,et al.  Measurement of myocardial mechanics in mice before and after infarction using multislice displacement-encoded MRI with 3D motion encoding. , 2005, American journal of physiology. Heart and circulatory physiology.

[206]  A. Haase,et al.  Perfusion‐corrected mapping of cardiac regional blood volume in rats in vivo , 1999, Magnetic resonance in medicine.

[207]  O Jolivet,et al.  Characterization of the skin in vivo by high resolution magnetic resonance imaging: water behavior and age-related effects. , 1993, The Journal of investigative dermatology.

[208]  R. Weissleder,et al.  Molecular imaging in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[209]  Noninvasive determination of regional cerebral blood flow in rats using dynamic imaging with Gd(DTPA) , 1991, Magnetic resonance in medicine.

[210]  J. Griffiths,et al.  Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo. , 1998, Cancer research.

[211]  L. Hedlund,et al.  MR Imaging with Hyperpolarized 3He Gas , 1995, Magnetic resonance in medicine.

[212]  A. N. Garroway Magic-angle sample spinning of liquids , 1982 .

[213]  L. Fig,et al.  Contemporary adrenal scintigraphy , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[214]  Ralph Weissleder,et al.  Molecular imaging in the clinical arena. , 2005, JAMA.

[215]  Fakhereh Mirrashed,et al.  In vivo morphological characterisation of skin by MRI micro‐imaging methods , 2004, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[216]  Isaac N. Bankman,et al.  Handbook of medical imaging , 2000 .

[217]  G. Guillot,et al.  The biochemical content of articular cartilage: an original MRI approach. , 2002, Biorheology.

[218]  G A Johnson,et al.  Magnetic resonance imaging of embryos: an Internet resource for the study of embryonic development. , 1999, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[219]  R. Weissleder,et al.  In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. , 2003, Cancer research.

[220]  J. Lindon,et al.  NMR‐based metabonomic approaches for evaluating physiological influences on biofluid composition , 2005, NMR in biomedicine.

[221]  R. Brooks,et al.  Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry. , 1998, Investigative radiology.

[222]  N. Beckman,et al.  In Vivo MR Techniques in Drug Discovery and Development , 2006 .

[223]  J. Fozard,et al.  Pulmonary edema induced by allergen challenge in the rat: Noninvasive assessment by magnetic resonance imaging , 2001, Magnetic resonance in medicine.

[224]  F. Gazeau,et al.  Single-cell detection by gradient echo 9.4 T MRI: a parametric study. , 2006, Contrast media & molecular imaging.

[225]  F. Gazeau,et al.  In vivo cellular imaging of lymphocyte trafficking by MRI: A tumor model approach to cell‐based anticancer therapy , 2006, Magnetic resonance in medicine.

[226]  S. Ogawa,et al.  Magnetic resonance imaging of blood vessels at high fields: In vivo and in vitro measurements and image simulation , 1990, Magnetic resonance in medicine.

[227]  B. Rosen,et al.  Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects , 1988, Magnetic resonance in medicine.

[228]  S. Galbraith,et al.  MR in oncology drug development , 2006, NMR in biomedicine.

[229]  D. Vanderhart Magnetic Susceptibility and High Resolution NMR of Liquids and Solids , 2007 .

[230]  P. Sadler,et al.  Insights into the mechanism of action of platinum anticancer drugs from multinuclear NMR spectroscopy , 2006 .

[231]  M. Rudin,et al.  Calcium Antagonists for Reduction of Brain Damage in Stroke , 1990, Journal of cardiovascular pharmacology.

[232]  J. Helpern,et al.  Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[233]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[234]  Markus Rudin,et al.  MRI Analysis of the Changes in Apparent Water Diffusion Coefficient, T2 Relaxation Time, and Cerebral Blood Flow and Volume in the Temporal Evolution of Cerebral Infarction Following Permanent Middle Cerebral Artery Occlusion in Rats , 2001, Experimental Neurology.

[235]  M. Jerosch-Herold,et al.  Myocardial blood flow quantification with MRI by model-independent deconvolution. , 2002, Medical physics.

[236]  Ravi S. Menon,et al.  Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[237]  M. Lowe Activated MR contrast agents. , 2004, Current pharmaceutical biotechnology.

[238]  Rong Zhou,et al.  Assessment of global and regional myocardial function in the mouse using cine and tagged MRI , 2003, Magnetic resonance in medicine.

[239]  M. Rudin,et al.  From anatomy to the target: Contributions of magnetic resonance imaging to preclinical pharmaceutical research , 2001, The Anatomical record.

[240]  N. Beckmann,et al.  Macrophage infiltration into the rat knee detected by MRI in a model of antigen‐induced arthritis , 2003, Magnetic resonance in medicine.

[241]  Atle Bjørnerud,et al.  The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system , 2004, NMR in biomedicine.

[242]  T. Reese,et al.  In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives , 1999, NMR in biomedicine.

[243]  S. Gronemeyer,et al.  Applications of 3D contrast-enhanced MR angiograpy in pediatric oncology , 1999, Pediatric Radiology.

[244]  J. Lindon,et al.  Characterization of in vitro metabolites from human liver microsomes using directly coupled hplc-nmr: application to a phenoxathiin monoamine oxidase-A inhibitor. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[245]  J. Bulte,et al.  Dy‐DTPA derivatives as relaxation agents for very high field MRI: The beneficial effect of slow water exchange on the transverse relaxivities , 2002, Magnetic resonance in medicine.

[246]  Han Wen,et al.  Noninvasive measurement of myocardial tissue volume change during systolic contraction and diastolic relaxation in the canine left ventricle , 2006, Magnetic resonance in medicine.

[247]  P. Anelli,et al.  Gd(DOTP)5‐ outer‐sphere relaxation enhancement promoted by nitrogen bases , 1993, Magnetic resonance in medicine.

[248]  J. Bassingthwaighte,et al.  Modeling regional myocardial flows from residue functions of an intravascular indicator. , 1996, The American journal of physiology.

[249]  M. Rudin,et al.  Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists. , 1988, Neurochemical pathology.

[250]  Susumu Mori,et al.  Magnetic resonance microscopy and histology of the CNS , 2002 .

[251]  Raoul Kopelman,et al.  Brain cancer diagnosis and therapy with nanoplatforms. , 2006, Advanced drug delivery reviews.

[252]  H. Pfeifer Principles of Nuclear Magnetic Resonance Microscopy , 1992 .

[253]  William R. Hendee,et al.  Medical Imaging Physics, 4th Edition , 2002 .

[254]  D. Larkman,et al.  A rapid method for labelling CD4+ T cells with ultrasmall paramagnetic iron oxide nanoparticles for magnetic resonance imaging that preserves proliferative, regulatory and migratory behaviour in vitro. , 2006, Journal of immunological methods.

[255]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[256]  A Sauter,et al.  In vivo pharmacokinetics using MRS , 1999, NMR in biomedicine.

[257]  Enzo Terreno,et al.  Tunable imaging of cells labeled with MRI-PARACEST agents. , 2005, Angewandte Chemie.

[258]  J. Ruíz-Cabello,et al.  Magnetic resonance microscopy versus light microscopy in human embryology teaching , 2004, Clinical anatomy.

[259]  Y. Ni,et al.  Dynamic susceptibility contrast-enhanced perfusion MR imaging at 1.5 T predicts final infarct size in a rat stroke model , 2005, Journal of Neuroscience Methods.

[260]  Henrik Antti,et al.  Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. , 2003, Toxicology and applied pharmacology.

[261]  Non-invasive analysis of rat ovarian angiogenesis by MRI , 2002, Molecular and Cellular Endocrinology.

[262]  Stefan Neubauer,et al.  Analysis of right ventricular function in healthy mice and a murine model of heart failure by in vivo MRI. , 2002, American journal of physiology. Heart and circulatory physiology.

[263]  Arthur W. Toga,et al.  A 3D digital map of rat brain , 1995, Brain Research Bulletin.

[264]  V. Ferrari,et al.  Quantitative assessment of regional myocardial function in a rat model of myocardial infarction using tagged MRI , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[265]  Edna Furman-Haran,et al.  The application of NMR in tumor angiogenesis research , 2006 .

[266]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[267]  D. S. Williams,et al.  Magnetic resonance imaging of perfusion using spin inversion of arterial water. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[268]  Massimo Filippi,et al.  Conventional MRI in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[269]  J. Hu,et al.  In vivo and ex vivo high-resolution 1H NMR in biological systems using low-speed magic angle spinning , 2006 .

[270]  D. Rugar,et al.  Nuclear magnetic resonance imaging with 90-nm resolution. , 2007, Nature Nanotechnology.

[271]  Orazio Schillaci,et al.  Single-photon emission computed tomography/computed tomography in brain tumors. , 2007, Seminars in nuclear medicine.

[272]  E. Purcell,et al.  Effects of Diffusion on Free Precession in Nuclear Magnetic Resonance Experiments , 1954 .

[273]  Bradford A Moffat,et al.  The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[274]  N. Beckmann,et al.  High-resolution three-dimensional magnetic resonance imaging for the investigation of knee joint damage during the time course of antigen-induced arthritis in rabbits. , 1999, Arthritis and rheumatism.

[275]  H. Kauczor,et al.  Hyperpolarised gases in magnetic resonance: a new tool for functional imaging of the lung. , 2001, Swiss medical weekly.